Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noriyuki Takai

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Current Genomics|May 9, 2009
Array-based approaches for the identification of epigenetic silenced tumor suppressor genesNoriyuki Takai, Hisashi Narahara
Cancers|November 28, 2013
Epigenetic therapy in human choriocarcinomaNoriyuki Takai, Hisashi Narahara
Current Medicinal Chemistry|November 6, 2007
Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosisNoriyuki Takai, Hisashi Narahara
Journal of Oncology|January 7, 2010
Histone deacetylase inhibitor therapy in epithelial ovarian cancerNoriyuki Takai, Hisashi Narahara
Obstetrics and Gynecology International|February 20, 2010
Preclinical studies of chemotherapy using histone deacetylase inhibitors in endometrial cancerNoriyuki Takai, Hisashi Narahara
The Journal of Obstetrics and Gynaecology Research|June 17, 2009
Multimodal treatment for glassy cell carcinoma of the uterine cervixKaei Nasu, Noriyuki Takai, Hisashi Narahara
Oncogene|January 11, 2005
Polo-like kinases (Plks) and cancerNoriyuki Takai, Ryoji Hamanaka, Jun Yoshimatsu, et al.
Gynecologic Oncology|September 16, 2008
Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cellsNoriyuki Takai, Tami Ueda, Kaei Nasu, et al.
Clinical Medicine. Pathology|August 31, 2011
Tumorigenic effects of tamoxifen on the female genital tractKaei Nasu, Noriyuki Takai, Masakazu Nishida, et al.
Acta Obstetricia Et Gynecologica Scandinavica|August 23, 2008
Glassy cell carcinoma arising in the vaginaKaei Nasu, Chieko Hamasaki, Noriyuki Takai, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Current Genomics|May 9, 2009
Array-based approaches for the identification of epigenetic silenced tumor suppressor genesNoriyuki Takai, Hisashi Narahara
Cancers|November 28, 2013
Epigenetic therapy in human choriocarcinomaNoriyuki Takai, Hisashi Narahara
Current Medicinal Chemistry|November 6, 2007
Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosisNoriyuki Takai, Hisashi Narahara
Journal of Oncology|January 7, 2010
Histone deacetylase inhibitor therapy in epithelial ovarian cancerNoriyuki Takai, Hisashi Narahara
Obstetrics and Gynecology International|February 20, 2010
Preclinical studies of chemotherapy using histone deacetylase inhibitors in endometrial cancerNoriyuki Takai, Hisashi Narahara
The Journal of Obstetrics and Gynaecology Research|June 17, 2009
Multimodal treatment for glassy cell carcinoma of the uterine cervixKaei Nasu, Noriyuki Takai, Hisashi Narahara
Oncogene|January 11, 2005
Polo-like kinases (Plks) and cancerNoriyuki Takai, Ryoji Hamanaka, Jun Yoshimatsu, et al.
Gynecologic Oncology|September 16, 2008
Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cellsNoriyuki Takai, Tami Ueda, Kaei Nasu, et al.
Clinical Medicine. Pathology|August 31, 2011
Tumorigenic effects of tamoxifen on the female genital tractKaei Nasu, Noriyuki Takai, Masakazu Nishida, et al.
Acta Obstetricia Et Gynecologica Scandinavica|August 23, 2008
Glassy cell carcinoma arising in the vaginaKaei Nasu, Chieko Hamasaki, Noriyuki Takai, et al.
Pageof 9